Marksans Pharma Limited (NSE: MARKSANS)
India
· Delayed Price · Currency is INR 263.09
+4.09 (1.58%)
Sep 6, 2024, 3:30 PM IST
Marksans Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 6, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 119,223 | 68,836 | 31,903 | 18,627 | 20,445 | 5,689 | Upgrade
|
| Market Cap Growth | 74.39% | 115.77% | 71.27% | -8.89% | 259.35% | -44.29% | Upgrade
|
| Enterprise Value | 114,866 | 63,549 | 29,746 | 16,052 | 19,467 | 6,163 | Upgrade
|
| Last Close Price | 263.09 | 151.90 | 70.01 | 45.03 | 49.26 | 13.68 | Upgrade
|
| PE Ratio | 35.75 | 21.95 | 10.92 | 9.87 | 8.45 | 4.64 | Upgrade
|
| PS Ratio | 5.26 | 3.16 | 1.72 | 1.25 | 1.49 | 0.50 | Upgrade
|
| PB Ratio | 5.77 | 3.30 | 1.81 | 1.52 | 2.26 | 0.88 | Upgrade
|
| P/FCF Ratio | - | 319.14 | 17.36 | 35.19 | 15.47 | 3.28 | Upgrade
|
| P/OCF Ratio | - | 29.88 | 13.44 | 18.77 | 11.45 | 2.44 | Upgrade
|
| EV/Sales Ratio | 5.06 | 2.92 | 1.61 | 1.08 | 1.41 | 0.54 | Upgrade
|
| EV/EBITDA Ratio | 23.51 | 14.65 | 9.29 | 6.68 | 5.81 | 3.25 | Upgrade
|
| EV/EBIT Ratio | 28.43 | 16.54 | 10.34 | 7.50 | 6.30 | 3.62 | Upgrade
|
| EV/FCF Ratio | - | 294.63 | 16.19 | 30.33 | 14.73 | 3.55 | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.12 | 0.07 | 0.09 | 0.04 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.50 | 0.53 | 0.36 | 0.43 | 0.12 | 0.18 | Upgrade
|
| Debt / FCF Ratio | - | 11.32 | 0.67 | 2.09 | 0.30 | 0.20 | Upgrade
|
| Asset Turnover | - | 0.89 | 0.97 | 1.04 | 1.29 | 1.33 | Upgrade
|
| Inventory Turnover | - | 1.94 | 2.07 | 1.76 | 1.87 | 2.15 | Upgrade
|
| Quick Ratio | - | 2.99 | 3.34 | 2.09 | 1.62 | 1.47 | Upgrade
|
| Current Ratio | - | 4.78 | 4.91 | 3.37 | 3.02 | 2.59 | Upgrade
|
| Return on Equity (ROE) | - | 16.35% | 17.76% | 17.55% | 30.69% | 20.09% | Upgrade
|
| Return on Assets (ROA) | - | 9.86% | 9.39% | 9.33% | 18.13% | 12.47% | Upgrade
|
| Return on Capital (ROIC) | 11.97% | 11.39% | 11.16% | 11.75% | 23.74% | 15.80% | Upgrade
|
| Earnings Yield | 2.80% | 4.56% | 8.35% | 10.03% | 11.67% | 21.22% | Upgrade
|
| FCF Yield | 0.31% | 5.76% | 2.84% | 6.46% | 30.48% | Upgrade
| |
| Dividend Yield | 0.23% | 0.39% | 0.71% | 0.56% | 0.51% | 0.73% | Upgrade
|
| Payout Ratio | 0.00% | 7.22% | 3.82% | 5.66% | 1.72% | 24.43% | Upgrade
|
| Buyback Yield / Dilution | -6.46% | -9.09% | -1.49% | - | 0.00% | - | Upgrade
|
| Total Shareholder Return | -6.23% | -8.70% | -0.77% | 0.56% | 0.51% | 0.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.